UK regulator says benefits of AstraZeneca vaccine outweigh risks

MHRA on the vaccine

Officials note that they're looking into 5 UK reports of a very rare and specific type of blood clot in the cerebral veins. They say problems have occurred in less than 1 in 1 million people and there's no evidence that it's occurring more than would be expected without the vaccine.

Best in 2026

Sponsored

General Risk Warning
investingLive Premium
Telegram Community
Gain Access